Ocumension Therapeutics announced that Ms. Pui Chun Hannah SUEN who is a joint company secretary of the Company has tendered her resignation as the manager of corporate services of Vistra Corporate Services (HK) Limited,
which is the external corporate services provider of the Company. As a result of the aforesaid resignation, Ms. SUEN ceased to act as (i) the Joint Company Secretary; (ii) an authorized representative of the Company pursuant to Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and (iii) an authorized representative of the Company to accept service of process and notices on behalf of the Company in Hong Kong as required under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) with effect from June 15, 2022. Following the cessation of Ms. SUEN to act as a Joint Company Secretary, the Board announce that Ms. CHAU Hing Ling has been appointed as a Joint Company Secretary, the Authorized Representative and the Process Agent with effect from June 15, 2022. Ms. Yun JI will continue to serve as the other Joint Company Secretary. Ms. JI was appointed as the Secretary of the Board and the Joint Company Secretary on April 28, 2020. Ms. Ji has been strategic project director since February 27, 2020, responsible for IPO project and the following capitalization operation. Prior to joining Group, from September 2012 to February 2020, she served as head manager of board of directors office in Shanghai Pharmaceuticals Holding Co. Ltd. a company whose shares are listed on the Shanghai Stock Exchange and the Stock Exchange where she led a team responsible for corporate governance, public disclosure, investor relations management and other securities affairs. Ms. CHAU is currently an executive director of corporate services of Vistra Corporate Services (HK) Limited. She has over twenty years of experience in the corporate services industry. She is currently the company secretary/joint company secretaries of certain listed companies. Ms. CHAU obtained a master of laws majoring in corporate and financial law from The University of Hong Kong in November 2007. She has been a fellow member of The Hong Kong Chartered Governance Institute and a fellow member of The Chartered Governance Institute in United Kingdom since May 2013.